Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Latest filing published 22 Nov 2019 for CELGENE CORP /DE/.
Filing timeline
BuySaleMichael D. Casey
Insider track record
Disclosed buys
0
Disclosed sells
28
Signal history
Michael D. Casey: trading record in brief
Michael D. Casey is a declared insider at 5 companies; the most frequent names are Celgene Corp /DE/, Abaxis Inc and Cholestech Corporation. The record holds 107 filings, for trades running from 10 January 2006 to 20 November 2019.
The open-market record consists of 28 sales worth €28.9M, with no purchase. Other entries cover 5 share grants and 61 option exercises.
Most recently, on 22 November 2019, the filings show a transaction in Celgene Corp /DE/. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael D. Casey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations106 total
143,638 shares0Common StockSEC:0001415889-19-001366:0
484 shares0Common StockSEC:0001415889-19-000731:0
300 shares0Common StockSEC:0001415889-19-000731:1
375 shares0Common StockSEC:0001415889-19-000731:2
24,666 shares@ US$22.4723.8% of flowCommon StockSEC:0001415889-19-000660:0
29,200 sharesCommon StockSEC:0001140361-18-035271:0
334 shares0Common StockSEC:0001415889-18-000948:0
300 shares0Common StockSEC:0001415889-18-000938:0
375 shares0Common StockSEC:0001415889-18-000938:1
27,750 shares@ US$30.015.7% of flowCommon StockSEC:0001415889-18-000918:0
13,000 shares@ US$78.777.1% of flowCommon StockSEC:0001415889-18-000918:1
5,500 shares0Common StockSEC:0001140361-18-021356:0
1,410 shares@ US$71.0028.2% of flowCommon StockSEC:0001140361-18-012896:0
563 shares@ US$71.0111.3% of flowCommon StockSEC:0001140361-18-012896:1
662 shares@ US$71.0213.2% of flowCommon StockSEC:0001140361-18-012896:2
65 shares@ US$71.041.3% of flowCommon StockSEC:0001140361-18-012896:3
300 shares@ US$71.086.0% of flowCommon StockSEC:0001140361-18-012896:4
300 shares@ US$71.096.0% of flowCommon StockSEC:0001140361-18-012896:5
1,700 shares@ US$71.1534.0% of flowCommon StockSEC:0001140361-18-012896:6
9,250 shares@ US$27.181.7% of flowCommon StockSEC:0001209191-18-015094:0
9,250 shares@ US$24.971.6% of flowCommon StockSEC:0001209191-17-051773:0
9,250 shares@ US$139.038.8% of flowCommon StockSEC:0001209191-17-051773:1
734 shares0Common StockSEC:0001209191-17-043762:0
9,250 shares@ US$33.882.3% of flowCommon StockSEC:0001209191-17-041632:0
9,250 shares@ US$133.059.0% of flowCommon StockSEC:0001209191-17-041632:1
25 of 106 declarations
